We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.37B
Cap. Flow %
8.51%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.76%
2 Technology 16.21%
3 Consumer Discretionary 13.94%
4 Industrials 11.16%
5 Communication Services 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSX icon
1
Boston Scientific
BSX
$67.7B
$363M 2.25%
8,435,415
-567,255
-6% -$21.8M
ZTS icon
2
Zoetis
ZTS
$31.7B
$344M 2.13%
3,027,988
-751,782
-20% -$78.7M
META icon
3
Meta Platforms (Facebook)
META
$1.47T
$323M 2%
1,671,746
+1,424,922
+577% +$260M
FIS icon
4
Fidelity National Information Services
FIS
$21.5B
$309M 1.92%
2,515,607
+741,411
+42% +$87.1M
AMZN icon
5
Amazon
AMZN
$2.87T
$299M 1.86%
3,160,680
+165,840
+6% +$15.4M
BA icon
6
Boeing
BA
$164B
$289M 1.79%
793,577
+413,478
+109% +$151M
DHR icon
7
Danaher
DHR
$152B
$288M 1.79%
2,276,611
-109,603
-5% -$13M
SEE
8
DELISTED
Sealed Air
SEE
$273M 1.69%
6,380,988
+237,126
+4% +$10.4M
MRK icon
9
Merck
MRK
$364B
$253M 1.57%
3,163,473
+299,018
+10% +$22.9M
ADBE icon
10
Adobe
ADBE
$116B
$244M 1.51%
827,114
+84,772
+11% +$23.5M
MSFT icon
11
Microsoft
MSFT
$3.82T
$241M 1.49%
1,796,863
+244,360
+16% +$31M
GILD icon
12
Gilead Sciences
GILD
$181B
$231M 1.43%
3,418,196
+2,559,972
+298% +$168M
BABA icon
13
Alibaba
BABA
$295B
$227M 1.41%
1,337,515
+1,326,579
+12,130% +$229M
BERY
14
DELISTED
Berry Global Group, Inc.
BERY
$226M 1.4%
4,684,850
+850,044
+22% +$41M
USFD icon
15
US Foods
USFD
$23.2B
$204M 1.27%
5,704,112
+268,974
+5% +$9.77M
DIS icon
16
Walt Disney
DIS
$186B
$198M 1.23%
1,419,786
+747,247
+111% +$99.1M
IDXX icon
17
Idexx Laboratories
IDXX
$43.5B
$192M 1.19%
698,227
+294,186
+73% +$72.5M
DGX icon
18
Quest Diagnostics
DGX
$26.8B
$181M 1.13%
1,780,582
+448,332
+34% +$43.1M
PTC icon
19
PTC
PTC
$17.2B
$179M 1.11%
1,995,589
+530,204
+36% +$47.5M
SPGI icon
20
S&P Global
SPGI
$131B
$177M 1.1%
776,583
+22,464
+3% +$4.91M
EA
21
DELISTED
Electronic Arts
EA
$164M 1.02%
1,623,809
+360,208
+29% +$34.3M
VRTX icon
22
Vertex Pharmaceuticals
VRTX
$138B
$162M 1.01%
884,990
+92,983
+12% +$16.3M
TFX icon
23
Teleflex
TFX
$5.91B
$159M 0.99%
479,934
-14,848
-3% -$4.48M
ABT icon
24
Abbott
ABT
$195B
$158M 0.98%
+1,884,363
New +$148M
HUM icon
25
Humana
HUM
$47B
$142M 0.88%
536,275
+528,637
+6,921% +$134M
1
2 3 4 5

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.37B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.